EP Patent

EP1342470B1 — Fast release cefuroxime axetil compositions

Assigned to Orbus Pharma Inc · Expires 2007-08-15 · 19y expired

What this patent protects

Fast release formulations of CefuroximeAxetil based on agents effecting channel formation through the matrix in order to avoid gelatination, and rapidly dissolved coating effected by incorporation of a surfactant into a water-soluble polymer.

USPTO Abstract

Fast release formulations of CefuroximeAxetil based on agents effecting channel formation through the matrix in order to avoid gelatination, and rapidly dissolved coating effected by incorporation of a surfactant into a water-soluble polymer.

Drugs covered by this patent

Patent Metadata

Patent number
EP1342470B1
Jurisdiction
EP
Classification
—
Expires
2007-08-15
Drug substance claim
No
Drug product claim
No
Assignee
Orbus Pharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.